Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?

Adv Exp Med Biol. 2001:489:13-29. doi: 10.1007/978-1-4615-1277-6_2.
No abstract available

Publication types

  • Review

MeSH terms

  • Arteriosclerosis / blood
  • Arteriosclerosis / epidemiology*
  • Arteriosclerosis / etiology
  • Arteriosclerosis / physiopathology
  • Bernard-Soulier Syndrome / blood
  • Bernard-Soulier Syndrome / epidemiology*
  • Bernard-Soulier Syndrome / ethnology
  • Blood Platelet Disorders / epidemiology
  • Blood Platelet Disorders / genetics
  • Blood Platelets / metabolism
  • Cytokines / metabolism
  • Cytoplasmic Granules / metabolism
  • DNA Mutational Analysis
  • Disease Susceptibility
  • Ethnicity / genetics
  • Female
  • Genetic Heterogeneity
  • Growth Substances / metabolism
  • Humans
  • Male
  • Mutation
  • Myocardial Infarction / epidemiology
  • Platelet Adhesiveness
  • Platelet Aggregation
  • Platelet Glycoprotein GPIIb-IIIa Complex / genetics
  • Platelet Glycoprotein GPIIb-IIIa Complex / physiology
  • Platelet Glycoprotein GPIb-IX Complex / genetics
  • Platelet Glycoprotein GPIb-IX Complex / physiology
  • Platelet Membrane Glycoproteins / deficiency*
  • Platelet Membrane Glycoproteins / genetics
  • Platelet Membrane Glycoproteins / physiology
  • Receptors, Vitronectin / genetics
  • Receptors, Vitronectin / physiology
  • Sequence Deletion
  • Thrombasthenia / blood
  • Thrombasthenia / epidemiology*
  • Thrombasthenia / ethnology

Substances

  • Cytokines
  • Growth Substances
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Glycoprotein GPIb-IX Complex
  • Platelet Membrane Glycoproteins
  • Receptors, Vitronectin